Featured Research

from universities, journals, and other organizations

Scientists discover effects of PD-1 blockade on ART therapy in SIV-infected monkeys

Date:
March 8, 2012
Source:
Emory University
Summary:
Scientists have discovered that blocking PD-1, an immune molecule that inhibits the immune response to viral infections, can have a significant effect on HIV-like illness in non-human primates.

Scientists have discovered that blocking PD-1 (programmed death-1), an immune molecule that inhibits the immune response to viral infections, can have a significant effect on HIV-like illness in nonhuman primates.

In earlier research, the scientists showed that PD-1 blockade could restore T and B cell function against SIV. Now they have new findings about the effects of PD-1 blockade along with antiretroviral therapy (ART).

Vijayakumar Velu, PhD, a scientist at Yerkes National Primate Research Center and the Emory Vaccine Center presented the information at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle, Wash. Rama Rao Amara, PhD, associate professor of microbiology and immunology at Yerkes and the Emory Vaccine Center, led the project.

The researchers treated SIV-infected rhesus macaque monkeys with ART from 16 to 21 weeks post infection then interrupted the therapy. The SIV viral load rapidly increased, along with the frequency of SIV-specific CD8 T cells. Four weeks later, the researchers treated some of the macaques with anti-PD-1 antibody and monitored both the treated and control animals.

Half the animals treated with PD-1 blockade, but only those with measurable CD8 T cells at the time of ART interruption, had a rapid decline in plasma viral load. PD-1 blockade did not enhance the frequency of SIV-specific CD8 T cells, but rather enhanced their function.

"Our results show PD-1 blockade after ART interruption can significantly enhance viral control, but the effect seems to depend on maintaining measurable SIV-specific CD8 T cell response following therapy," says Velu.

Rafi Ahmed, director of the Emory Vaccine Center and a key member of this research team, first identified the PD-1 molecule as a target for therapy designed to reactivate exhausted immune cells in chronic diseases. Other members of the research team are Gordon J. Freeman of Harvard Medical School and Kehmia Titanji, Ravi Dyavar Shetty and Hyun Woo Lee from Yerkes and the Emory Vaccine Center. The team plans to continue studying the interactive effects of PD-1 blockade combined with ART.


Story Source:

The above story is based on materials provided by Emory University. Note: Materials may be edited for content and length.


Cite This Page:

Emory University. "Scientists discover effects of PD-1 blockade on ART therapy in SIV-infected monkeys." ScienceDaily. ScienceDaily, 8 March 2012. <www.sciencedaily.com/releases/2012/03/120308174929.htm>.
Emory University. (2012, March 8). Scientists discover effects of PD-1 blockade on ART therapy in SIV-infected monkeys. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2012/03/120308174929.htm
Emory University. "Scientists discover effects of PD-1 blockade on ART therapy in SIV-infected monkeys." ScienceDaily. www.sciencedaily.com/releases/2012/03/120308174929.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins